Name

CLAG

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for CLAG

Name

Alternate Names

2-Chlorodeoxyadenosine
Chlorodeoxyadenosine
CldAdo
Leustatin
RWJ 26251
RWJ-26251
RWJ26251

Abbreviations

2CdA

Category

Chemotherapy

Subcategory

Antimetabolite
purine analogs

NSC Number

105014

Primary Site

Leukemia
Leukemic reticuloendotheliosis

Histology

None

Remarks

FDA approved for hairy cell leukemia treatment.
Currently in trials for other B cell leukemias and lymphomas, such as mantle cell lymphoma. Also used in the treatment of multiple sclerosis.

Coding

This drug should be coded

Name

Alternate Names

AC-1075
Alexan
Ara-cytidine
Arabinocytidine
Arabinosylcytosine
Beta-Arabinosylcytosine
Cytarabin
Cytarabine
Cytarabinoside
Cytosar
Cytosar-U
Cytosine Arabinoside
Cytosine arabinoside hydrochloride
Spongocytidine HCL
Tarabine
Tarabine PFS
U-19920
U-19920A
WR-28453

Abbreviations

ara-C
CA
HDA
HDARA-C

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

063878
63878

Primary Site

ALL
AML
CML
head and neck
Hodgkin's disease
leukemia
Meningeal leukemia
NHL

Histology

None

Remarks

Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)

Coding

This drug should be coded
Glossary